Kiniksa Pharmaceuticals International (KNSA) EBIT Growth (1y) (2018 - 2026)
Kiniksa Pharmaceuticals International (KNSA) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 25.63% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.30% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -14.89% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -46.83% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 719.49% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 23.29% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -450.06% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -235.28% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -20.32% |
| 10 | Kiniksa Pharmaceuticals International | 3.73 Bn | 3.26 Bn | 193.47 Mn | 120.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.52% |
| Dec 31, 2025 | -82.07% |
| Sep 30, 2025 | 348.72% |
| Jun 30, 2025 | 17,330.77% |
| Mar 31, 2025 | 180.23% |
| Dec 31, 2024 | -23,925.93% |
| Sep 30, 2024 | 11.61% |
| Jun 30, 2024 | 96.29% |
| Mar 31, 2024 | -47.75% |
| Dec 31, 2023 | -98.66% |
| Sep 30, 2023 | -123.54% |
| Jun 30, 2023 | 83.72% |
| Mar 31, 2023 | 51.99% |
| Dec 31, 2022 | 116.74% |
| Sep 30, 2022 | 251.35% |
| Jun 30, 2022 | 52.24% |
| Mar 31, 2022 | 52.68% |
| Dec 31, 2021 | 77.04% |
| Mar 31, 2021 | -67.70% |
| Dec 31, 2020 | -382.99% |